Cytoprotection: shelter from the storm.
Klein
P
P
Kaplan Comprehensive Cancer Center, New York University Medical Center, New York City, USA.
Muggia
F M
FM
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000931:Antidotes / Q000627:therapeutic use; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D019610:Cytoprotection; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects; D004334:Drug Administration Schedule; D005493:Folic Acid Antagonists / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects
D000903:Antibiotics, Antineoplastic; D000931:Antidotes; D000964:Antimetabolites, Antineoplastic; D005493:Folic Acid Antagonists; D004317:Doxorubicin; D002955:Leucovorin; D008727:Methotrexate